CID 146271223

Eratrectinib

Structural Information

Molecular Formula
C21H22FN7O
SMILES
C1C[C@@H]2C3=C(CCN(NC(=O)C4=C5N=C(N2C1)C=CN5N=C4)C6CC6)N=CC(=C3)F
InChI
InChI=1S/C21H22FN7O/c22-13-10-15-17(23-11-13)5-8-28(14-3-4-14)26-21(30)16-12-24-29-9-6-19(25-20(16)29)27-7-1-2-18(15)27/h6,9-12,14,18H,1-5,7-8H2,(H,26,30)/t18-/m1/s1
InChIKey
URXMBXJZRCIDQB-GOSISDBHSA-N
Compound name
(6R)-15-cyclopropyl-9-fluoro-2,11,15,16,20,21,24-heptazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

407.18698 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 408.19426 204.4
[M+Na]+ 430.17620 215.1
[M-H]- 406.17970 200.6
[M+NH4]+ 425.22080 206.0
[M+K]+ 446.15014 205.9
[M+H-H2O]+ 390.18424 196.3
[M+HCOO]- 452.18518 209.2
[M+CH3COO]- 466.20083 208.6
[M+Na-2H]- 428.16165 201.7
[M]+ 407.18643 201.9
[M]- 407.18753 201.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe